StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Sorrento Therapeutics stock opened at $0.01 on Tuesday. Sorrento Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.25. The company has a 50 day moving average of $0.01 and a 200-day moving average of $0.01.
About Sorrento Therapeutics
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- How to Use the MarketBeat Excel Dividend Calculator
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- Stock Dividend Cuts Happen Are You Ready?
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.